A New clinical score for disease activity in Langerhans cell histiocytosis
Pediatric Blood & Cancer2004Vol. 43(7), pp. 770–776
Citations Over TimeTop 18% of 2004 papers
Jean Donadieu, Christophe Piguet, Frédéric Bernard, Mohamed Barkaoui, Marie Ouache, Y. Bertrand, H. Ibrahim, Jean‐François Emile, Olivier Hermine, Abdellatif Tazi, T Généreau, Caroline Thomas
Abstract
This LCH disease activity score provides an objective tool for assessing disease severity, both at diagnosis and during follow-up and treatment.
Related Papers
- → Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study(2018)33 cited
- → Imaging findings in Langerhans' cell histiocytosis of the liver and the spleen in an adult(1999)18 cited
- → [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].(2013)
- → Association of Langerhans Cell Histiocytosis with Erdheim-Chester Disease: How Close Monocyte/Macrophage and Dendritic Cell Lineages Are?(2010)